Associate Professor, Department of Surgical Oncology
General Surgery
Dr. Richard J. Bleicher, MD
|
|
Give Review
Richard Bleicher is an expert in the field of General Surgery. He attended Temple University School of Medicine. He received 3 awards: "Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification" and "Fellow". Richard J. Bleicher is a published physician as well. He has 41 publications published. The latest was: ATP-dependent transport of glutathione conjugate of 7beta, 8alpha-dihydroxy-9alpha,10alpha-oxy-7,8,9,10-tetrahydrobenzo[a]pyrene in murine hepatic canalicular plasma m... Richard Bleicher is registered with Medicare and accepts Medicare payments.
Publications
- Multifocal and Multicentric Breast Cancer is Associated with Increased Local Recurrence Regardless of Surgery Type.
- Reply to E.A. Peralta et al.
- Risk of Positive Nonsentinel Nodes in Women with 1-2 Positive Sentinel Nodes Related to Age and Molecular Subtype Approximated by Receptor Status.
- Patterns of nodal staging during Breast conservation surgery in the medicare patient: will the ACOSOG Z0011 trial change the pattern of care?
- Reply to letter: "anaplastic large cell lymphomas and Breast implants".
- Ductal Carcinoma in situ.
- Identifying patients who may be candidates for a clinical trial of salvage accelerated partial Breast irradiation after previous whole Breast irradiation.
- Advanced imaging modalities in early stage breast Cancer: preoperative use in the United States Medicare population.
- The Effect of Simultaneous Peripheral Excision in Breast Conservation upon Margin Status.
- Five-year results of whole breast intensity modulated radiation therapy for the treatment of early stage breast Cancer: the Fox Chase Cancer Center experience.
- Five-year Local Control in a Phase II Study of Hypofractionated Intensity Modulated Radiation Therapy With an Incorporated Boost for Early Stage Breast Cancer.
- Lymphatic Space Invasion is Not an Independent Predictor of Outcomes in Early Stage Breast Cancer Treated by Breast-Conserving Surgery and Radiation.
- Impact of the Radiation Boost on Outcomes After Breast-Conserving Surgery and Radiation.
- History of smoking is associated with younger age at diagnosis of breast Cancer.
- Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status.
- Young age is not associated with increased local recurrence for DCIS treated by Breast-conserving surgery and radiation.
- Inflammatory cutaneous adverse effects of methylene blue dye injection for lymphatic mapping/sentinel lymphadenectomy.
- A prospective feasibility trial to determine the significance of the sentinel node gradient in breast Cancer: a predictor of nodal metastasis location.
- Beauty and the beast: management of breast Cancer after plastic surgery.
- The influence of age on the Breast surgery decision-making process.
- Estrogen receptor-negative invasive breast Cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression.
- MRI and breast Cancer: role in detection, diagnosis, and staging.
- Lymphatic mapping and sentinel lymphadenectomy for primary and metastatic pulmonary malignant neoplasms.
- Overexpression of glucosylceramide synthase and P-glycoprotein in Cancer cells selected for resistance to natural product chemotherapy.
- Skin-sparing mastectomy. specialty bias and worldwide lack of consensus.
- The selective use of sentinel node biopsy in ductal Carcinoma in situ.
- Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas.
- Radiofrequency ablation in 447 complex unresectable liver Tumors: lessons learned.
- Invasive mucinous carcinoma arising in ectopic axillary Breast tissue: a case report and literature review.
- Sentinel lymphadenectomy: a new alternative for managing early breast Cancer.
- Prognostic implications of thick (>or=4-mm) melanoma in the era of intraoperative lymphatic mapping and sentinel lymphadenectomy.
- Biochemical mechanism of cross-resistance to paclitaxel in a mitomycin c-resistant human bladder Cancer cell line.
- ATP-dependent transport of glutathione conjugate of 7beta, 8alpha-dihydroxy-9alpha,10alpha-oxy-7,8,9,10-tetrahydrobenzo[a]pyrene in murine hepatic canalicular plasma m...
- Induction of glutathione S-transferase pi as a bioassay for the evaluation of potency of inhibitors of benzo(a)pyrene-induced Cancer in a murine model.
- Characterization of a BMS-181174-resistant human bladder Cancer cell line.
- Active site architecture of polymorphic forms of human glutathione S-transferase P1-1 accounts for their enantioselectivity and disparate activity in the glutathione c...
- Mechanism of increased sensitivity to etoposide in a mitomycin C-resistant human bladder Cancer cell line.
- Bilateral gluteal compartment syndrome.
- Prophylactic ureteral catheterization in colon surgery. A five-year review.
- Glucosylceramide synthase and apoptosis.
Schools
Temple University School Of Medicine
Mercy Hospital
John Wayne Cancer Institute
Mercy HospitalResearch Fellowship
Procedures Preformed
- Biopsy of Breast
- Breast Cancer Treatment
- Breast Exam
- Breast Reconstruction
- View All
Conditions Treated
- Adrenal Gland Cancer
- Breast Cancer
- Breast Diseases
- Breast Lump
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Personal Choice PPO
- Regional Pref Network EPO
- Regional Pref Network HMO
- Regional Pref Network HMO+
- Regional Pref Network POS+
- Regional Pref Network PPO
- Assurant Health
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Geisinger Health Plan
- Community Blue PPO
- Direct Access
- Horizon Blue Cross Blue Shield HMO
- Horizon Blue Cross Blue Shield POS
- Horizon Blue Cross Blue Shield PPO
- Choice Care PPO
- Keystone Health Plan East HMO
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- QualCare HMO
- QualCare PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- PacifiCare HMO
- United Healthcare
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Fellow
Education
-
University of Pittsburgh Medical Center-Mercy Hospital -
Temple University School of Medicine
Hospital
-
Fox Chase Cancer Center-American Oncologic Hospital -
Temple University Hospital
Drug Facts
| NPI NUMBER | 1275584609 | |
| NPPES Provider LastName | BLEICHER | |
| NPPES Provider FirstName | RICHARD | |
| NPPES Provider ZIPCode | 191112434 | |
| NPPES Provider State | PA | |
| Specialty Description | Surgical Oncology | |
| Total Claim Count | 11.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1275584609 |
| Last Name Of The Provider | BLEICHER |
| First Name Of The Provider | RICHARD |
| View All |
Similar Doctors
|
Dr. Toby C. Tally, MD |
|
|
Dr. Kamran Khanmoradi, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric J. Maiorino, MD |
|
|
Dr. Ashok K. Jain, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathleen A. Holoyda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Austin D. Williams, MD |
|
|
Dr. S S. Vedula, MD |
|
|
Dr. Dhananjay H. Shirgavi, MD |
|
|
Dr. Caroline E. Reinke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Howard M. Ross, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter A. Mattei, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|